Research progress on combination therapy in inflammatory bowel disease
Inflammatory bowel disease(IBD)is a refractory intestinal inflammatory disease,the failure of pharmaco-kinetics and pharmacodynamic evasion has led to the current single-targeted therapy based treatment is restricted,and the unsatisfactory treatment of severe and extraparenteral manifestations has accelerated the progress of research on com-bination therapy.The previous mature combination therapy cases have further promoted the research of dual-targeted therapy regimens.This article reviewed the combination therapy for IBD.
NETL
NSTL
万方数据
维普
